rs766488017
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_004369.4(COL6A3):c.4121A>T(p.Asp1374Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000775 in 1,613,478 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. D1374D) has been classified as Likely benign.
Frequency
Consequence
NM_004369.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
COL6A3 | NM_004369.4 | c.4121A>T | p.Asp1374Val | missense_variant | 9/44 | ENST00000295550.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
COL6A3 | ENST00000295550.9 | c.4121A>T | p.Asp1374Val | missense_variant | 9/44 | 1 | NM_004369.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000461 AC: 7AN: 151728Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251286Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135812
GnomAD4 exome AF: 0.0000807 AC: 118AN: 1461750Hom.: 0 Cov.: 31 AF XY: 0.0000853 AC XY: 62AN XY: 727154
GnomAD4 genome ? AF: 0.0000461 AC: 7AN: 151728Hom.: 0 Cov.: 32 AF XY: 0.0000540 AC XY: 4AN XY: 74052
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Dec 09, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 01, 2019 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Identified in heterozygous state in an individual with isolated dystonia (Zech et al., 2015); also reported in an individual with clinically suspected LGMD (Nallamilli et al., 2018); This variant is associated with the following publications: (PMID: 30564623, 26004199) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 12, 2016 | - - |
Bethlem myopathy 1A Pathogenic:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Dec 14, 2023 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Dec 03, 2017 | - - |
Ullrich congenital muscular dystrophy 1A Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The missense variant c.4121A>T (p.Asp1374Val) in COL6A3 gene has been reported in heterozygous state in individual affected with limb-girdle muscular dystrophy (Nallamilli et al.,2018). This variant is reported with the allele frequency (0.01%) in the gnomAD and novel in 1000 genome database. It has been submitted to ClinVar with varying interpretations: Likely Pathogenic / Uncertain Significance. The amino acid Aspartic acid at position 1374 is changed to a Valine changing protein sequence and it might alter its composition and physico-chemical properties. The variant is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at